Science & Co Review: What Its $59 and $99 GLP-1 Prices Actually Tell You

The most important number missing from Science & Co’s advertised GLP-1 pricing is the amount a patient would actually pay at checkout. Compounded semaglutide injections start at $59 a month and compounded tirzepatide injections at $99 a month, but both minimums are tied to 12-month plans. The supplied pages do not establish whether those plans require upfront payment, what the initial charge is or how leaving early affects the price. Those gaps matter more to a household budget than the smaller monthly figure alone.

This documentary review examines Science & Co’s public product pages, FAQ, contact information and terms consulted October 19, 2026. The business advertises telehealth access to injectable and oral GLP-1 treatments, including compounded preparations and branded products. Its terms identify Science and Co, Inc., a Delaware corporation, as the administrative and technology platform—not the medical practice or dispensing pharmacy. The central purchasing question is therefore twofold: what payment arrangement are you accepting, and which independent organization is responsible for each part of the service?

At a glance

Compounded semaglutide starting price: Injection plans start at $59 a month on a 12-month plan; the initial collection amount is not established in the supplied pages.
Sources: [11]
Compounded tirzepatide starting price: Injection plans start at $99 a month on a 12-month plan, with the provider advertising the same price across doses.
Sources: [12]
Recurring billing: Subscription payments recur automatically at intervals disclosed during checkout until cancellation.
Sources: [9]
Cancellation deadline: Pause or cancel at least 72 hours before the next scheduled processing date; cancellation does not reverse an already prescribed, dispensed or shipped order.
Sources: [11] [6]
Cash-pay restriction: Science & Co does not submit insurance claims, and its terms prohibit seeking reimbursement from public or private healthcare payors for services or products obtained through the platform.
Sources: [6] [9]

Start with the first charge, not the monthly headline

Science & Co attaches its lowest advertised compounded-injection prices to 12-month plans: $59 a month for semaglutide and $99 a month for tirzepatide. A separate personalized GLP-1/GIP-1 injection page also advertises plans starting at $59 a month on a 12-month plan. None of those statements, by itself, establishes monthly collection, mandatory annual prepayment or the amount due today. The personalized product’s cited heading also does not identify its exact active ingredient, making a written product description as important as a written payment schedule.

The semaglutide page displays a $149 reference price and an advertised 60% saving; the tirzepatide page displays $199 and an advertised 50% saving. Those are the provider’s promotional comparisons, not independently established savings. The homepage separately promotes 20% off the first month and a free online provider evaluation, without explaining whether that offer combines with the 12-month minimums. Before authorizing payment, request the first charge, subsequent charges and applicable promotion in one written quote. Our guide to the first GLP-1 payment explains why those figures can differ.

What the advertised prices establish—and what they leave open
Offer	Documented price condition	Still to confirm
Compounded semaglutide injection	Starting at $59/month on a 12-month plan	First charge and early-exit price treatment
Compounded tirzepatide injection	Starting at $99/month on a 12-month plan	First charge and billing interval
Personalized GLP-1/GIP-1 injection	Starting at $59/month on a 12-month plan	Exact ingredient and payment schedule
First-month promotion	20% off first month; free online provider evaluation	Eligibility and combination with other offers
Branded injections and tablets	No concrete prices in supplied pages	Product-specific total and recurring charges

Sources: [11] [12] [13] [3]

A 12-month price is not a complete subscription contract

The terms say subscription purchases generate automatic charges at the recurring intervals disclosed for the selected product during checkout, continuing until cancellation. That makes checkout documentation essential: the public monthly price does not settle the billing interval. Likewise, the 12-month plan label does not establish a particular medication quantity or a minimum treatment commitment. There is an unresolved tension between the long-plan price condition and the product page’s statement that there is no lock-in. The supplied material does not explain the financial consequences of ending such a plan early.

The cancellation language is more specific than the price language. Science & Co says patients can pause or cancel without a cancellation fee from their account, provided they act at least 72 hours before the next scheduled processing date. The FAQ also permits cancellation or pausing by emailing support@science.co. The deadline concerns processing, not the expected delivery date. Because cancellation stops future orders but does not reverse an order already prescribed, dispensed or shipped, the useful calendar entry is the processing deadline—not simply the day medication usually arrives.

Sources: [9] [11] [6]

The bundle includes care and shipping, but not every possible expense is resolved

On the compounded semaglutide page, Science & Co describes a package that includes an online assessment reviewed by a licensed clinician, treatment planning, clinically appropriate dose adjustments, secure messaging and scheduled check-ins. It also lists supplies, shipping and ongoing clinical monitoring. The compounded semaglutide and tirzepatide pricing descriptions say there is no monthly membership fee and advertise the same price at starting and higher doses. These are meaningful inclusions, although they should be matched to the exact product and plan in the patient’s quote rather than assumed to apply identically across the entire catalog.

The terms explain that the total subscription price can include pharmacy charges for the prescription, professional-entity charges for clinical services and platform-access fees. That allocation is consistent with a bundled bill; it does not establish that each participant will bill separately. Still unresolved is whether laboratory work, if requested, is included. Nor do the supplied pages establish the cost consequences of using an outside pharmacy. A useful comparison therefore separates expressly included items from unpriced contingencies, as outlined in our guide to what a GLP-1 program price includes.

Sources: [11] [12] [9]

Self-pay means more than the absence of insurance billing

Science & Co’s FAQ describes the service as cash pay and says it does not submit claims to insurance, Medicare or Medicaid. Its terms go further: neither the patient nor the participating platform, clinicians, professional entities or pharmacies may seek or receive reimbursement from federal, state or private healthcare payors for products or services supplied through the platform. Consequently, a prospective customer should not interpret “no insurance required” as permission to pay first and submit these charges to an insurer later. The stated reimbursement restriction deserves attention before enrollment.

The FAQ separately says treatment is generally HSA- and FSA-eligible and offers itemized receipts. That is a provider statement, not a determination that a particular account will accept every expense. Request an itemized description and confirm the account administrator’s requirements rather than relying on the marketing phrase alone. The distinction matters because payment-account documentation and insurance reimbursement are different questions. Our insurance and self-pay guide provides a framework for separating coverage, claims submission and the amount a patient must personally fund.

Sources: [6] [9]

Product choice changes what the price comparison means

The documented catalog extends beyond the two prominently priced compounded injections. Science & Co advertises Zepbound tirzepatide injections from Eli Lilly and Wegovy semaglutide injections from Novo Nordisk. It also advertises Wegovy semaglutide tablets and Foundayo orforglipron tablets. Concrete branded-product prices are absent from the supplied pages, so the $59 and $99 minimums should not be applied to them. The tablet pages describe their products as manufacturer-made, sealed, unaltered, noncompounded and FDA approved; those are provider assertions here, not independently verified product findings.

The microdose GLP-1/GIP-1 injection should not be treated as a confirmed available option: its dedicated page says “Coming Soon,” despite conflicting catalog labeling. The broader catalog also lists injectable NAD+ and sermorelin under longevity, separate from these GLP-1 offerings. Science & Co acknowledges that compounded drugs are not FDA approved. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence, but neither the platform nor its compounded preparations acquire FDA approval from a branded product’s status.

Sources: [11] [12] [4] [7] [8] [10] [5] [3] [1]

Follow the money through the clinical and pharmacy handoffs

Science and Co, Inc. says it connects users with independent licensed clinicians; professional entities provide healthcare, and independent pharmacies dispense prescriptions. The terms advertise service in all 50 states and the District of Columbia, only for people located within the United States, and require users to be at least 18. Those access rules are not clinical eligibility guarantees. The supplied pages do not identify the specific professional entity, prescriber or pharmacy that would serve an individual patient, so those names remain useful prepayment questions.

The process begins with an approximately five-minute online questionnaire described as carrying no initial commitment. Sample intake questions cover previous GLP-1 use, type 2 diabetes, thyroid history, and pregnancy or nursing, without supplying complete exclusion rules. Science & Co says most reviews finish within 24–48 hours; that is a review estimate, not a delivery promise. A prescription requires a completed consultation, a clinician’s determination of appropriateness and an issued prescription. The company also says the prescriber is licensed in the patient’s state and no medication is dispensed without approval.

Sources: [9] [11]

Shipping and quality claims need product-specific answers

Science & Co advertises free home shipping and says medication arrives on a monthly schedule. The supplied material does not establish carriers, preparation time, transit time, cold-chain conditions or procedures for lost or damaged shipments. Its terms allow patients to request that an issued prescription be sent to a pharmacy of their choice, but do not establish whether the advertised bundle price and shipping arrangement survive that change. They also warn that pharmacy products may not arrive in child-resistant packaging. Free delivery is a documented benefit, not a complete fulfillment policy.

For compounded medication, the company says it works only with state-licensed U.S. compounding pharmacies, has every batch independently tested for purity and potency, and makes a Certificate of Analysis available on request. These claims were not independently verified. Ask which pharmacy will dispense the specific prescription and which documentation applies to it. The review did not include the Shipping & Returns page, so a complete replacement or refund policy cannot be established. Separately, FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated, and contacting the provider or dispensing pharmacy.

Sources: [11] [9] [1]

Budget for an ongoing service, not just a recurring shipment

Science & Co says the same clinician stays with a patient month to month and adjusts treatment according to response. It advertises secure messaging, scheduled check-ins and 24/7 support, meaning patients can message the care team at any time; no guaranteed response time is documented. The materials also do not establish one contractual check-in frequency: monthly check-ins appear alongside an illustrative interface describing weekly check-ins during the first eight weeks. Ask which schedule applies to the purchased plan and how clinical concerns are handled between appointments.

For existing members, the contact page calls account messaging the fastest route for treatment, order and plan questions. The company also publishes support@science.co and 1 (844) 587-5747. Its contact page excludes medical emergencies and directs people to 911 or an emergency department. For billing disputes, keep the checkout terms, processing dates and cancellation confirmation: a no-fee cancellation promise is not a refund promise. Our guide to cancellation and refunds explains that distinction. The remaining financial question is what happens to money already collected when future treatment or shipments stop.

Sources: [6] [11] [2] [9]

Questions & answers

Can I buy Science & Co compounded semaglutide for one month at $59?

The supplied pages do not establish that option. They attach the starting $59 monthly figure to a 12-month compounded semaglutide injection plan. They also advertise no lock-in, but do not explain how that promise interacts with long-plan pricing. Ask for the amount due today, the next charge, and what you would owe or receive back if you stopped after the first month. Do not treat the headline as a confirmed stand-alone monthly purchase price.

Sources: [11]

Will the compounded tirzepatide price rise with a higher dose?

Science & Co says its compounded tirzepatide price stays the same between starting and higher doses. Its advertised minimum is $99 a month on a 12-month plan, with no monthly membership fee and free shipping. That statement addresses dose-related pricing, not every future renewal condition. The supplied material does not establish a broader price guarantee beyond the quoted arrangement, and a branded Zepbound prescription should not be assumed to carry this compounded-product price.

Sources: [12] [4]

Can I cancel by email, and will that produce a refund?

The FAQ permits pausing or canceling through the account or by emailing support@science.co at least 72 hours before the next processing date. The product page says cancellation has no fee and stops future orders, but does not reverse an order already prescribed, dispensed or shipped. A complete refund policy was not established from the consulted material. Ask specifically about unused prepaid amounts and already processed orders; cancellation permission alone does not answer either question.

Sources: [6] [11]

Can I use my own pharmacy instead of Science & Co’s pharmacy channel?

The terms allow an issued prescription to be sent to a pharmacy of the patient’s choice. That is a documented option, but the supplied pages do not explain the resulting price arrangement. Before switching, ask whether medication charges are removed from the platform bill, whether the outside pharmacy can fulfill the exact prescription, and who handles shipping and fulfillment problems. The right to choose a pharmacy does not establish that the advertised bundle transfers unchanged.

Sources: [9]

Does the free evaluation guarantee a prescription?

No. The homepage advertises a free online provider evaluation, and the product page describes the initial questionnaire as carrying no commitment. The terms nevertheless require a completed consultation, a clinician’s determination that the product is appropriate, and an issued prescription before a prescription product can be supplied. The company’s 24–48-hour estimate concerns most clinical reviews, not guaranteed approval or delivery. The supplied material does not fully explain what happens to any collected payment if treatment is declined.

Sources: [3] [11] [9]

What should I request before authorizing recurring payments?

Request a product-specific quote naming the formulation and route, the first collection amount, billing interval, next processing date and rules for leaving the 12-month plan. Also ask for the dispensing pharmacy’s name, whether requested labs cost extra, and the applicable refund or replacement policy. Those questions address gaps in this record rather than implying that a particular charge will occur. Save the answers alongside the checkout terms, especially if relying on a first-month promotion.

Sources: [9] [11] [3]

Our assessment

Science & Co documents a potentially useful bundle: clinical review, ongoing messaging and monitoring, supplies, and free shipping, with dose-independent advertised pricing for its compounded semaglutide and tirzepatide injections. It also provides a specific cancellation deadline and multiple contact routes. The principal cost limitation is not the absence of a headline price; it is the missing connection between that price and the actual payment obligation. The $59 and $99 minimums require 12-month plans, while the supplied pages leave first collection, early-exit accounting and complete refund boundaries unresolved. Branded-product pricing is also unavailable here. A practical next step is to obtain those terms in writing before authorizing recurring charges, rather than treating either the low monthly figure or the no-lock-in language as a complete financial agreement.

Visit Science & Co’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Science & Co Review: What Its $59 and $99 GLP-1 Prices Actually Tell You

At a glance

01Start with the first charge, not the monthly headline

02A 12-month price is not a complete subscription contract

03The bundle includes care and shipping, but not every possible expense is resolved

04Self-pay means more than the absence of insurance billing

05Product choice changes what the price comparison means

06Follow the money through the clinical and pharmacy handoffs

07Shipping and quality claims need product-specific answers

08Budget for an ongoing service, not just a recurring shipment